EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,287 Cr | ₹971 Cr | ₹727 Cr | ₹747 Cr | ₹973 Cr |
| Adjustment | ₹555 Cr | ₹552 Cr | ₹543 Cr | ₹492 Cr | ₹399 Cr |
| Changes In working Capital | ₹-530 Cr | ₹-424 Cr | ₹51 Cr | ₹-292 Cr | ₹-292 Cr |
| Cash Flow after changes in Working Capital | ₹1,312 Cr | ₹1,099 Cr | ₹1,321 Cr | ₹947 Cr | ₹1,079 Cr |
| Cash Flow from Operating Activities | ₹944 Cr | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr |
| Cash Flow from Investing Activities | ₹-1,193 Cr | ₹-94 Cr | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr |
| Cash Flow from Financing Activities | ₹343 Cr | ₹-814 Cr | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr |
| Net Cash Inflow / Outflow | ₹94 Cr | ₹-56 Cr | ₹221 Cr | ₹134 Cr | ₹-172 Cr |
| Opening Cash & Cash Equivalents | ₹-14 Cr | ₹44 Cr | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | ₹214 Cr |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹18 Cr | ₹-2.05 Cr | ₹-2.00 Cr | ₹-0.13 Cr | ₹0.19 Cr |
| Closing Cash & Cash Equivalent | ₹98 Cr | ₹-14 Cr | ₹44 Cr | ₹-175 Cr | ₹-308 Cr |
Compare Cashflow Statement of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹44,375.6 Cr | 5.6% | 27.4% | 72.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 5.6% |
27.4% |
72.5% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses